Anio Pharma ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Anio Pharma ApS
Anio Pharma ApS (CVR number: 39932229) is a company from GENTOFTE. The company recorded a gross profit of -24.7 kDKK in 2019. The operating profit was -24.7 kDKK, while net earnings were -19.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -51 %, which can be considered poor and Return on Equity (ROE) was -62.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 63.4 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Anio Pharma ApS's liquidity measured by quick ratio was 2.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | |
---|---|
Volume | |
Net sales | |
Gross profit | -24.73 |
EBIT | -24.73 |
Net earnings | -19.29 |
Shareholders equity total | 30.71 |
Balance sheet total (assets) | 48.48 |
Net debt | -41.19 |
Profitability | |
EBIT-% | |
ROA | -51.0 % |
ROE | -62.8 % |
ROI | -80.5 % |
Economic value added (EVA) | -19.29 |
Solvency | |
Equity ratio | 63.4 % |
Gearing | |
Relative net indebtedness % | |
Liquidity | |
Quick ratio | 2.7 |
Current ratio | 2.7 |
Cash and cash equivalents | 41.19 |
Capital use efficiency | |
Trade debtors turnover (days) | |
Net working capital % | |
Credit risk | |
Credit rating | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.